Ferroelectric
materials have a variety of technological applications,
as transducers, capacitors, sensors, etc. Great interest in molecular
ferroelectrics has emerged because of their structural flexibility,
tunability, and homochirality. However, the discoveries of molecular
ferroelectrics are not abundant. The lack of chemical design
is the main challenge in realizing new molecular ferroelectrics.
Consequently, chemical design approaches, including the ideas of introducing
quasi-spherical theory, homochirality, and H/F substitution, have
been developed recently. Through these advanced methodologies, a wide
range of ferroelectrics were successfully synthesized, changing
the blind search into a targeted chemical design. In this Perspective,
we aim to provide insight into the fundamental chemistry and physics
of molecular ferroelectrics and propose the concept of “ferroelectrochemistry”,
concerned with the targeted design and performance optimization of
molecular ferroelectrics from the chemical point of view. We
start with the basic theories used in the modification of chemical
structures for new molecular ferroelectrics, such as the quasi-spherical
theory. After that, we focus on the fundamentals of homochirality
from the perspective of chemistry and advantages of introducing a
homochiral molecule within the scope of ferroelectrics. Further,
we explore another design strategy, H/F substitution, as an analogue
of the H/D isotope effect. The introduction of a F atom usually does
not change the polar point group but may induce a minor structural
disruption that enhances physical properties such as Curie temperature
and spontaneous polarization. We hope our comprehensive studies on
the targeted design and performance optimization strategies for molecular
ferroelectrics may build up and enrich the content of ferroelectrochemistry.
Spelling is an important application of brain-computer interfaces (BCIs). Previous BCI spellers were not suited for widespread use due to their low information transfer rate (ITR). In this study, we constructed a high-ITR BCI speller based on the steady-state visual evoked potential (SSVEP). A 45-target BCI speller was implemented with a frequency resolution of 0.2 Hz. A sampled sinusoidal stimulation method was used to present visual stimuli on a conventional LCD screen. The online results revealed that the proposed BCI speller had a good performance, reaching a high average accuracy (84.1% for 2 s stimulation time; 90.2% for 3 s stimulation time) and the corresponding high ITR (105 bits/min for 2 s stimulation time, 82 bits/min for 3 s stimulation time) during the low-frequency stimuli, while 88.7% and 61 bits/ min were achieved for a 4 s time window during the high-frequency stimuli.
Schizophrenia is a severe mental disorder characterized by impaired perception, delusions, thought disorder, abnormal emotion regulation, altered motor function, and impaired drive. The default mode network (DMN), since it was first proposed in 2001, has become a central research theme in neuropsychiatric disorders, including schizophrenia. In this review, first we define the DMN and describe its functional activity, functional and anatomical connectivity, heritability, and inverse correlation with the task positive network. Second, we review empirical studies of the anatomical and functional DMN, and anti-correlation between DMN and the task positive network in schizophrenia. Finally, we review preliminary evidence about the relationship between antipsychotic medications and regulation of the DMN, review the role of DMN as a treatment biomarker for this disease, and consider the DMN effects of individualized therapies for schizophrenia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.